Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METHYR: Metformin and fertility in women receiving iodine-131 for papillary thyroid cancer
2021-005366-17Phase 3Active
- Sponsor
- Medical University of Białystok
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of metformin in papillary thyroid cancer (PTC) and thyroid cancer (2 arms), sponsored by Medical University of Białystok. Primary endpoint: Change in ovarian reserve markers and antral follicle count. Started Feb 2022; status: active.
02
Drugs
metformin
03
Conditions
papillary thyroid cancer (PTC)thyroid cancer
Beyond the preview
Go deeper on 2021-005366-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005366-17.